Celiing Biosciences

---

www.cellingbiosciences.com

Celling Biosciences is a transformative leader innovating cellular therapy by integrating excellence in research, medical education, advocacy, and product development.

Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.

Technologies developed by Celling Biosciences collect, process and deliver autologous cells to the patient at the point of care. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process.

Celling Biosciences takes a systematic approach of tissue collection, processing and concentrating cells to address the clinical needs of physicians proving autologous cell therapy to their patients.

The Autologous Regenerative Therapies (ART) product portfolio was designed for the optimal processing of tissue at the point of care to isolate certain cells for autologous cellular collection.

The ART BMC concentration system recovers a high percentage of nucleated, progenitor and other cells by allowing selection of the cell concentrate from user-defined portions of the centrifuged stack. This miniaturized laboratory is designed as a single use sterile device that delivers a safe handling of cells.

• Functionally closed system limits sterile breaks
• Processes up to 60cc of aspirate
• Thumb wheel allows precise selection of fluid stack

The ART BMC PLUS features an integrated filter system for the ultrafiltration of proteins from bone derived from bone marrow.

• Efficient concentration yields of ultra low hematocrit
• Concentration of molecules including: fibrinogen, alpha-2-maro globulin and cytokines.
• Consistently high yields of mononuculear cells

Celling Biosciences ART PRP products are engineered to effectively and efficiently concentrate platelets and growth factors from whole blood. The design allows a user to select the desired layer of the centrifuged stack in a controlled manner.

The ART PRP system processes autologous whole blood effectively and efficiently at the point of care. The system recovers the greatest percentage of platelets and growth factors by allowing selection of the platelet concentrate from user defined portions of a centrifuged stack of fluid.

• Thumb wheel technology for efficient stack layer extraction
• Adjustable flow valve diverts fluid without additional sterile breaks
• Variable processing volume supports a variety of applications

The ART PRP PLUS system has an integrated filter system for the ultrafiltration of proteins from platelet poor plasma (PPP).

• Integrated nano-pore fiber system
• Closed system technology limits sterile breaks
• Thumb wheel technology allows precise recovery of targeted cell layer in the collection zone
• Large collection window

The ART Two Step PRP device features a dual-chamber design allowing the user to perform either leukocyte rich or leukocyte poor platelet-rich plasma. The product uses Celling Bioscience’s patented collection window and dial mechanism allowing precision control to achieve a high yield of platelets in a PRP volume that can be customized to the physician’s clinical requirements.

• One disposable can perform two different PRP techniques
  • 1 spin method for leukocyte rich PRP
  • 2 spin method for leukocyte poor PRP
• Input volume 45-60cc
• Refined collection window geometry and positioning

*Pending FDA Approval